The elevated expression of ERK5 contributes for tumor cell growth, tumor metastasis, worse prognosis and increased therapeutical resistance in multiple cancer types such as in breast, prostate, and colon cancers, hepatocellular carcinomas, and osteosarcomas64,65. This evidence concerns the gene MAPK7 and colonic neoplasm.